QurAlis Corporation
Latest round
- Series B
Last raised
- Dec 2022
Total raised
- $93M
Investors
- 15
About QurAlis Corporation
Founded in 2016 and headquartered in Cambridge, US, QurAlis Corporation is dedicated to developing innovative therapies targeting neurodegenerative disease mechanisms. Kasper Roet, the founder, has a background in the biotech sector, contributing expertise to the company's vision.QurAlis specializes in developing precision medicines aimed at treating neurodegenerative diseases, focusing on amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Their proprietary FLEXASO® platform utilizes anti-sense oligonucleotide splice modulation to create therapeutic candidates that target ALS pathology through specific genetic and clinical biomarkers.QurAlis generates revenue through strategic partnerships and collaborations to advance its therapeutic candidates. The company structures agreements around milestone payments and royalties, providing access to its FLEXASO® platform and pipeline therapeutics for partner development.
Who invested in QurAlis Corporation
15 investors across 4 rounds
See all investors in QurAlis Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about QurAlis Corporation
Who invested in QurAlis Corporation?
QurAlis Corporation has 15 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has QurAlis Corporation raised?
QurAlis Corporation has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did QurAlis Corporation last raise money?
QurAlis Corporation's most recent round on record is a Series B, in Dec 2022.
What does QurAlis Corporation do?
Founded in 2016 and headquartered in Cambridge, US, QurAlis Corporation is dedicated to developing innovative therapies targeting neurodegenerative disease mechanisms.
Where is QurAlis Corporation headquartered?
QurAlis Corporation is headquartered in Cambridge, US.
Which VCs invest in companies like QurAlis Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at QurAlis Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like QurAlis Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.